ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Inter individual apoptotic variability as a result of polymorphisms in apoptosis pathway related genes can influence the response to IM in CML patients and can be a possible BCR-ABL independent mechanism mediating resistance.